Description

DILZEM CD 120 MG

Indications

DILZEM CD 120 MG is primarily indicated for the treatment of hypertension (high blood pressure) and angina pectoris (chest pain). It is also used in certain cases of supraventricular tachycardia, a condition characterized by an abnormally fast heart rate originating above the ventricles. By managing these conditions, DILZEM CD helps to reduce the risk of cardiovascular events such as heart attacks and strokes.

Mechanism of Action

DILZEM CD contains the active ingredient Diltiazem, which is a calcium channel blocker. It works by inhibiting the influx of calcium ions into cardiac and smooth muscle cells during depolarization. This action leads to relaxation of vascular smooth muscle, resulting in vasodilation (widening of blood vessels) and a decrease in peripheral vascular resistance. Consequently, Diltiazem reduces the workload on the heart and lowers blood pressure. Additionally, it decreases heart rate and myocardial oxygen demand, which is beneficial in managing angina symptoms.

Pharmacological Properties

Diltiazem exhibits a unique pharmacological profile as it possesses both vasodilatory and antiarrhythmic properties. It is classified as a benzothiazepine derivative and has a moderate effect on cardiac contractility. DILZEM CD is formulated as a controlled-release capsule, allowing for sustained therapeutic effects over a 24-hour period. The bioavailability of Diltiazem is approximately 40-50%, and it undergoes extensive hepatic metabolism, primarily by cytochrome P450 enzymes. The elimination half-life of Diltiazem ranges from 3 to 5 hours, although the controlled-release formulation extends its duration of action.

Contraindications

DILZEM CD should not be used in patients with known hypersensitivity to Diltiazem or any of its components. It is contraindicated in individuals with severe hypotension (low blood pressure), advanced atrioventricular block (unless a pacemaker is present), sick sinus syndrome, or acute myocardial infarction with pulmonary congestion. Caution should be exercised in patients with liver dysfunction, as the metabolism of Diltiazem may be impaired.

Side Effects

Common side effects associated with DILZEM CD include headache, dizziness, fatigue, and gastrointestinal disturbances such as nausea and constipation. Less frequently, patients may experience bradycardia (slow heart rate), peripheral edema (swelling of the limbs), and skin rashes. Serious side effects, although rare, can include severe hypotension, heart block, and liver enzyme elevations. Patients should be monitored for any adverse reactions, especially during the initial stages of treatment or when the dosage is adjusted.

Dosage and Administration

The recommended starting dose of DILZEM CD for adults is typically 120 mg once daily. Depending on the patient’s response and tolerance, the dosage may be adjusted, with a maximum recommended dose of 360 mg per day. It is advisable to take DILZEM CD at the same time each day to maintain consistent blood levels. The capsules should be swallowed whole and not crushed or chewed, as this may alter the controlled-release properties. Patients are encouraged to follow their healthcare provider’s instructions regarding dosage adjustments and to report any side effects promptly.

Interactions

DILZEM CD may interact with various medications, which can affect its efficacy or increase the risk of adverse effects. Concomitant use of other antihypertensive agents may lead to additive effects, resulting in excessive hypotension. Diltiazem can also enhance the effects of anticoagulants like warfarin, necessitating careful monitoring of coagulation parameters. Additionally, caution is advised when DILZEM CD is used with drugs that are metabolized by cytochrome P450 3A4, such as certain statins and benzodiazepines, as this may lead to increased plasma concentrations of these medications. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and herbal supplements.

Precautions

Before initiating treatment with DILZEM CD, a thorough medical history and physical examination should be conducted. Special precautions should be taken in patients with a history of heart failure, as Diltiazem may exacerbate this condition. Regular monitoring of blood pressure and heart rate is recommended, particularly in elderly patients or those with pre-existing cardiovascular conditions. Patients should be advised to avoid abrupt discontinuation of DILZEM CD, as this may lead to rebound hypertension or exacerbation of angina symptoms. Alcohol consumption should also be limited, as it may enhance the hypotensive effects of the medication.

Clinical Studies

Clinical studies have demonstrated the efficacy of DILZEM CD in lowering blood pressure and reducing the frequency of angina episodes. In a randomized, double-blind study involving patients with essential hypertension, Diltiazem was shown to significantly reduce systolic and diastolic blood pressure compared to placebo. Another study focused on patients with stable angina pectoris indicated that DILZEM CD effectively increased exercise tolerance and reduced angina frequency. Long-term studies have also suggested that Diltiazem may contribute to improved outcomes in patients with coronary artery disease by reducing the risk of cardiovascular events.

Conclusion

DILZEM CD 120 MG is a valuable therapeutic option for managing hypertension and angina pectoris. Its unique mechanism of action as a calcium channel blocker provides effective blood pressure control and alleviates symptoms of angina. While generally well-tolerated, healthcare providers should be vigilant in monitoring for potential side effects and drug interactions. Individualized treatment plans and patient education are essential to optimize the benefits of DILZEM CD and ensure safe usage.